ACE2 and COVID-19: Molecular docking technology is widely used in COVID-19, such as the use of Huashi Baidu formula (HSBDF) in China to treat patients with severe COVID-19, where baicalein and quercetin were found to be compounds with high affinity for ACE2 through network pharmacology and molecular docking (Tao et al., 2020).